These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 31418750)

  • 1. Toxic epidermal necrolysis (Lyell syndrome) as a severe and fatal manifestation of multiple myeloma with amyloidosis in a patient with rapidly progressing end-stage renal disease.
    Kępska-Dzilińska M; Kohmann A; Kuriga M; Puła B; Matuszkiewicz-Rowińska J; Małyszko J
    Pol Arch Intern Med; 2019 Nov; 129(11):819-821. PubMed ID: 31418750
    [No Abstract]   [Full Text] [Related]  

  • 2. Dialysis Independence Following Combination Daratumumab, Thalidomide, Bortezomib, Cyclophosphamide, and Dexamethasone in Multiple Myeloma With Severe Renal Failure.
    Moore DC; Arnall JR; Janes A; Pineda-Roman M
    Clin Lymphoma Myeloma Leuk; 2020 Jul; 20(7):e395-e398. PubMed ID: 32359768
    [No Abstract]   [Full Text] [Related]  

  • 3. Toxic epidermal necrolysis induced by thalidomide and dexamethasone treatment for multiple myeloma.
    Hwang S; Woo Y; Kim M; Park HJ
    Int J Dermatol; 2017 Feb; 56(2):e35-e37. PubMed ID: 27805271
    [No Abstract]   [Full Text] [Related]  

  • 4. Paraneoplastic aortitis in a patient with relapsed multiple myeloma successfully treated with daratumumab, bortezomib and dexamethasone.
    Krečak I; Ruščić I; Zlatović JJ; Šupe M; Krečak MV; Gverić-Krečak V
    Ann Hematol; 2021 Jun; 100(6):1623-1624. PubMed ID: 33404692
    [No Abstract]   [Full Text] [Related]  

  • 5. Severe epidermal necrolysis after bortezomib treatment for multiple myeloma.
    Fang B; Song Y; Ma J; Zhao RC
    Acta Haematol; 2007; 118(2):65-7. PubMed ID: 17505132
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful treatment with bortezomib and dexamethasone for proliferative glomerulonephritis with monoclonal IgG deposits in multiple myeloma: a case report.
    Noto R; Kamiura N; Ono Y; Tabata S; Hara S; Yokoi H; Yoshimoto A; Yanagita M
    BMC Nephrol; 2017 Apr; 18(1):127. PubMed ID: 28385149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible lenalidomide-induced Stevens-Johnson syndrome during treatment for multiple myeloma.
    Boruah PK; Bolesta S; Shetty SM
    Pharmacotherapy; 2011 Sep; 31(9):925. PubMed ID: 21923596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bortezomib and Thalidomide Treatment Results in Newly Diagnosed Transplant-Ineligible Multiple Myeloma Patients are Comparable in Long-Term Follow-Up.
    Stork M; Sandecká V; Boichuk I; Adam Z; Krejci M; Brozova L; Sevcikova S; Pour L
    Klin Onkol; 2019; 32(6):445-452. PubMed ID: 31842563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal necrolysis and autoimmune diseases: two more observations supporting the concept that 'toxic' epidermal necrolysis can be 'non-toxic'.
    Dumas M; Hua C; Hotz C; Velter C; Duong TA; Maraffi T; Ortonne N; Hüe S; Fardet L; de Prost N; Wolkenstein P; Ingen-Housz-Oro S; Chosidow O
    J Eur Acad Dermatol Venereol; 2018 Sep; 32(9):e360-e361. PubMed ID: 29524279
    [No Abstract]   [Full Text] [Related]  

  • 10. Stevens-Johnson/toxic epidermal necrolysis overlap syndrome following lenalidomide treatment for multiple myeloma relapse after allogeneic transplantation.
    Wäsch R; Jakob T; Technau K; Finke J; Engelhardt M
    Ann Hematol; 2012 Feb; 91(2):287-9. PubMed ID: 21494796
    [No Abstract]   [Full Text] [Related]  

  • 11. The Addition of Low-dose Thalidomide to Bortezomib and Dexamethasone for Refractory Multiple Myeloma.
    Hashimoto S; Kuroha T; Yano T; Sato N; Furukawa T
    Intern Med; 2016; 55(20):3025-3028. PubMed ID: 27746443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxic epidermal necrolysis following thalidomide and dexamethasone treatment for multiple myeloma: a case report.
    Eo WK; Kim SH; Cheon SH; Lee SH; Jeong JS; Kim YS; Chang HK; Suh KS; Kim HY
    Ann Hematol; 2010 Apr; 89(4):421-2. PubMed ID: 19693501
    [No Abstract]   [Full Text] [Related]  

  • 13. Toxic epidermal necrolysis induced by vemurafenib.
    Lapresta A; Dotor A; González-Herrada C
    Actas Dermosifiliogr; 2015 Oct; 106(8):682-3. PubMed ID: 26051238
    [No Abstract]   [Full Text] [Related]  

  • 14. Bortezomib-induced cardiogenic shock in a multiple myeloma patient with K light-chain cardiac amyloidosis.
    Dammassa V; Greco A; Totaro R; Colombo CNJ; Raineri C; Camporotondo R; De Ferrari GM; Mojoli F; Arbustini E; Oltrona Visconti L; Tavazzi G
    Ann Hematol; 2022 Sep; 101(9):2087-2088. PubMed ID: 35538262
    [No Abstract]   [Full Text] [Related]  

  • 15. Toxic Epidermal Necrolysis-like Reaction With Severe Satellite Cell Necrosis Associated With Nivolumab in a Patient With Ipilimumab Refractory Metastatic Melanoma.
    Nayar N; Briscoe K; Fernandez Penas P
    J Immunother; 2016 Apr; 39(3):149-52. PubMed ID: 26938948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stevens-Johnson syndrome/toxic epidermal necrolysis overlap in a NSCLC patient treated with afatinib.
    Nühnen VP; Schön MP; Mössner R
    J Dtsch Dermatol Ges; 2018 Feb; 16(2):199-201. PubMed ID: 29328518
    [No Abstract]   [Full Text] [Related]  

  • 17. Steven's Johnson syndrome with toxic epidermal necrolysis due to thalidomide in a case of multiple myeloma.
    Das A; Sil A; Mishra V; Das NK
    Indian J Pharmacol; 2014; 46(5):557-9. PubMed ID: 25298592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclophosphamide in the treatment of toxic epidermal necrolysis.
    Frangogiannis NG; Boridy I; Mazhar M; Mathews R; Gangopadhyay S; Cate T
    South Med J; 1996 Oct; 89(10):1001-3. PubMed ID: 8865797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of bisphosphonates in patients with myeloma and renal failure.
    Saghafi D
    Mayo Clin Proc; 2003 Jan; 78(1):118; author reply 118. PubMed ID: 12528887
    [No Abstract]   [Full Text] [Related]  

  • 20. Stevens-Johnson syndrome and toxic epidermal necrolysis overlap in a patient receiving cetuximab and radiotherapy for head and neck cancer.
    Urosevic-Maiwald M; Harr T; French LE; Dummer R
    Int J Dermatol; 2012 Jul; 51(7):864-7. PubMed ID: 22715836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.